http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007039155-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d1596f64ec0b2dac5334b2cf05b88bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2632044442e0a90025c935598622a3be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7082e19ffa95ae997aa14929f7b0a04c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_161edaaa0b0e7f2304e270182fdf7440
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a3b5408ee3578bcb0fabe4794b2becc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
filingDate 2006-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40e71a35e4700de2e1321ffcf9608445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_864d341989fbbc06f39a271c03487432
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc85d8e0908b5b107ab5983e50b39bd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65df10502c43f736cf430d4c42733565
publicationDate 2007-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007039155-A2
titleOfInvention Use of soluble guanylate cyclase activators for treating acute and chronic lung diseases
abstract The present invention relates to the use of compounds of formulae I-VI for producing a drug for treating acute and chronic lung diseases, such as Respiratory Distress Syndrome [acute lung injury (ALI), acute respiratory distress syndrome (ARDS)], and for treating COPD.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102485724-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102485724-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011095534-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-025177-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101793304-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-202008014557-U1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2585055-A1
priorityDate 2005-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2395431-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005077005-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005042022-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005013691-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005089473-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006037491-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129166007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440995
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134396547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409751
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129701980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265

Total number of triples: 56.